Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02773524
Title A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEII)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Australasian Gastro-Intestinal Trials Group
Indications

stomach carcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Regorafenib

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.